Toon J I De Munck1,2, Pan Xu2, Harm J A Verwijs1, Ad A M Masclee1,2, Daisy Jonkers1,2, Jef Verbeek3, Ger H Koek1,2. 1. Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, the Netherlands. 2. School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands. 3. Department of Gastroenterology and Hepatology, University Hospitals KU Leuven, Leuven, Belgium.
Abstract
BACKGROUND: The gut-liver axis is considered to play a critical role in the development and progression of nonalcoholic fatty liver disease (NAFLD). The integrity of the epithelial barrier is crucial to protect the liver against the invasion of microbial products from the gut, although its exact role in NAFLD onset and progression is not clear. METHODS: We performed a systematic review and meta-analysis of studies that addressed the intestinal permeability (IP) in association with NAFLD presence or severity as defined by the presence of nonalcoholic steatohepatitis (NASH) and the degree of steatosis, hepatic inflammation or fibrosis. A total of 14 studies were eligible for inclusion. RESULTS: Studies investigating IP in adult (n = 6) and paediatric (n = 8) NAFLD showed similar results. Thirteen of the included studies focussed on small IP, two studies on whole gut permeability and none on colonic permeability. In the pooled analysis, NAFLD patients showed an increased small intestinal permeability compared to healthy controls based on dual sugar tests (standardized mean difference 0.79, 95% CI 0.49-1.08) and serum zonulin levels (standardized mean difference 1.04 ng/mL, 95% CI 0.40-1.68). No clear difference in IP was observed between simple steatosis and NASH patients. Furthermore, whole gut and small intestinal permeability increased with the degree of hepatic steatosis in 4/4 studies, while no association with hepatic inflammation or fibrosis was observed. CONCLUSION: Based on the limited number of studies available, IP appears to be increased in NAFLD patients compared to healthy controls and is associated with the degree of hepatic steatosis.
BACKGROUND: The gut-liver axis is considered to play a critical role in the development and progression of nonalcoholic fatty liver disease (NAFLD). The integrity of the epithelial barrier is crucial to protect the liver against the invasion of microbial products from the gut, although its exact role in NAFLD onset and progression is not clear. METHODS: We performed a systematic review and meta-analysis of studies that addressed the intestinal permeability (IP) in association with NAFLD presence or severity as defined by the presence of nonalcoholic steatohepatitis (NASH) and the degree of steatosis, hepatic inflammation or fibrosis. A total of 14 studies were eligible for inclusion. RESULTS: Studies investigating IP in adult (n = 6) and paediatric (n = 8) NAFLD showed similar results. Thirteen of the included studies focussed on small IP, two studies on whole gut permeability and none on colonic permeability. In the pooled analysis, NAFLD patients showed an increased small intestinal permeability compared to healthy controls based on dual sugar tests (standardized mean difference 0.79, 95% CI 0.49-1.08) and serum zonulin levels (standardized mean difference 1.04 ng/mL, 95% CI 0.40-1.68). No clear difference in IP was observed between simple steatosis and NASH patients. Furthermore, whole gut and small intestinal permeability increased with the degree of hepatic steatosis in 4/4 studies, while no association with hepatic inflammation or fibrosis was observed. CONCLUSION: Based on the limited number of studies available, IP appears to be increased in NAFLD patients compared to healthy controls and is associated with the degree of hepatic steatosis.
Authors: Kirsten E Pijls; Ger H Koek; Elhaseen E Elamin; Hanne de Vries; Ad A M Masclee; Daisy M A E Jonkers Journal: Am J Physiol Gastrointest Liver Physiol Date: 2013-11-21 Impact factor: 4.052
Authors: S Guercio Nuzio; M Di Stasi; L Pierri; J Troisi; M Poeta; A Bisogno; F Belmonte; M Tripodi; D Di Salvio; G Massa; R Savastano; P Cavallo; M Boffardi; D Ziegenhardt; I Bergheim; C Mandato; P Vajro Journal: Pediatr Obes Date: 2016-06-28 Impact factor: 4.000
Authors: Ashkan Farhadi; Sushama Gundlapalli; Maliha Shaikh; Constantine Frantzides; Laura Harrell; Mary M Kwasny; Ali Keshavarzian Journal: Liver Int Date: 2008-04-07 Impact factor: 5.828
Authors: Toon J I De Munck; Pan Xu; Harm J A Verwijs; Ad A M Masclee; Daisy Jonkers; Jef Verbeek; Ger H Koek Journal: Liver Int Date: 2020-10-21 Impact factor: 8.754
Authors: Eveline Gart; Kanita Salic; Martine C Morrison; Martin Giera; Joline Attema; Christa de Ruiter; Martien Caspers; Frank Schuren; Ivana Bobeldijk-Pastorova; Marianne Heer; Yan Qin; Robert Kleemann Journal: Front Nutr Date: 2022-06-17
Authors: Mia J Coleman; Luis M Espino; Hernan Lebensohn; Marija V Zimkute; Negar Yaghooti; Christina L Ling; Jessica M Gross; Natalia Listwan; Sandra Cano; Vanessa Garcia; Debbie M Lovato; Susan L Tigert; Drew R Jones; Rama R Gullapalli; Neal E Rakov; Euriko G Torrazza Perez; Eliseo F Castillo Journal: Metabolites Date: 2022-05-11
Authors: Toon J I De Munck; Pan Xu; Harm J A Verwijs; Ad A M Masclee; Daisy Jonkers; Jef Verbeek; Ger H Koek Journal: Liver Int Date: 2020-10-21 Impact factor: 8.754
Authors: Roberta Forlano; Benjamin H Mullish; Lauren A Roberts; Mark R Thursz; Pinelopi Manousou Journal: Int J Mol Sci Date: 2022-01-08 Impact factor: 5.923